Biology Reference
In-Depth Information
Wang H, Liu Y, Hou J, Zheng M, Robinson H, Ke H (2007) Structural insight into substrate
specificity of phosphodiesterase 10. Proc Natl Acad Sci USA 3;104:5782-5787
Wang H, Liu Y, Huai Q, Cai J, Zoraghi R, Francis SH, Corbin JD, Robinson H, Xin Z, Lin G, Ke H
(2006) Multiple conformations of phosphodiesterase-5: implications for enzyme function and
drug development. J Biol Chem 281:21469-21479
Wang H, Peng MS, Chen Y, Geng J, Robinson H, Houslay MD, Cai J, Ke H (2007) Structures
of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their
inhibitors. Biochem J 408:193-201
Wang H, Yan Z, Yang S, Cai J, Robinson H, Ke H (2008) Kinetic and structural studies of
phosphodiesterase-8A and implication on the inhibitor
selectivity. Biochemistry 47:
12760-12768
Wang H, Ye M, Robinson H, Francis SH, Ke H (2008) Conformational variations of both
phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects
of vardenafil and sildenafil. Mol Pharmacol 73:104-110
Weeks JL 2nd, Zoraghi R, Francis SH, Corbin JD (2007) N-Terminal domain of phosphodiesterase-
11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is
involved in oligomerization. Biochemistry 46:10353-10364
Wernet W, Flockerzi V, Hofmann F (1989) The cDNA of the two isoforms of bovine cGMP-
dependent protein kinase. FEBS Lett 251:191-196
Wilson LS, Elbatarny HS, Crawley SW, Bennett BM, Maurice DH (2008) Compartmentation and
compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-
mediated regulation of platelet functions. Proc Natl Acad Sci USA 105:13650-13655
Wu AY, Tang XB, Martinez SE, Ikeda K, Beavo JA (2004) Molecular determinants for cyclic
nucleotide binding to the regulatory domains of phosphodiesterase 2A. J Biol Chem 279:
37928-37938
Xu RX, Hassell AM, Vanderwall D, Lambert MH, Holmes WD, Luther MA, Rocque WJ, Milburn
MV, Zhao Y, Ke H, Nolte RT (2000) Atomic structure of PDE4: insights into phosphodiester-
ase mechanism and specificity. Science 288:1822-1825
Xu RX, Rocque WJ, Lambert MH, Vanderwall DE, Luther MA, Nolte RT (2004) Crystal structures
of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and
rolipram. J Mol Biol 337:355-365
Yamamoto T, Yamamoto S, Osborne JC Jr, Manganiello VC, Vaughan M, Hidaka H (1983)
Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
J Biol Chem 258:14173-14177
Yan C, Zhao AZ, Bentley JK, Beavo JA (1996) The calmodulin-dependent phosphodiesterase
gene PDE1C encodes several functionally different splice variants in a tissue-specific manner.
J Biol Chem 271:25699-25706
Yarwood SJ, Steele MR, Scotland G, Houslay MD, Bolger GB (1999) The RACK1 signaling
scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5
isoform. J Biol Chem 274:14909-14917
Zaccolo M, Pozzan T (2002) Discrete microdomains with high concentration of cAMP in
stimulated rat neonatal cardiac myocytes. Science 295:1711-1715
Zhang KYJ (2006) Crystal structure of phosphodiesterase families and the potential for rational
drug design. In: Beavo J, Francis SH, Houslay MD (eds) Cyclic nucleotide phosphodiesterase
in health and disease. CRC Press, Boca Raton, pp 583-605
Zhang W, Ke H, Colman RW (2002) Identification of interaction sites of cyclic nucleotide
phosphodiesterase type 3A with milrinone and cilostazol using molecular modeling and site-
directed mutagenesis. Mol Pharmacol 62:514-520
Zhang X, Feng Q, Cote RH (2005) Efficacy and selectivity of phosphodiesterase-targeted drugs in
inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors. Invest Ophthal-
mol Vis Sci 46:3060-3066
Zhang XJ, Skiba NP, Cote RH (2009) Structural requirements of the photoreceptor phosphodies-
terase {gamma}-subunit for inhibition of rod PDE6 holoenzyme and for its activation by
transducin. J Biol Chem 285:4455-4463
